About
Peptide Therapy
Areas of Focus
Categories
Gene Therapy, RNA & Peptide Therapy
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
5
As Collaborator
2
Total Enrollment
1,542
By Phase
NA: 1PHASE2: 3PHASE1: 1
By Status
COMPLETED: 4RECRUITING: 1UNKNOWN: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06580418Lead Sponsor
Evaluation of an Anti-TREM-1 Treatment on an ex Vivo Human Intestinal Model
N/ARecruiting
40 participants
Started: Jan 31, 2023 · Completed: Mar 31, 2025
NCT04948840Collaborator
Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary Fibrosis
NAUnknown
20 participants
Started: Apr 1, 2022 · Completed: Dec 31, 2024
NCT04544891Collaborator
TREM-1 Pathway Activation in COVID-19
N/ACompleted
830 participants
Started: Oct 1, 2020 · Completed: Mar 1, 2022
NCT04429334Lead Sponsor
Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support
PHASE2Completed
220 participants
Started: Sep 23, 2020 · Completed: Jun 22, 2022
NCT04055909Lead Sponsor
Efficacy, Safety and Tolerability of Nangibotide in Patients With Septic Shock
PHASE2Active, not recruiting
355 participants
Started: Nov 13, 2019 · Completed: May 9, 2023
Locations (1)
Headquarters
Paris, France
Map
Loading map...